{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:37:23Z","timestamp":1792121843874,"version":"4.4.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK056350"],"award-info":[{"award-number":["DK056350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI050410"],"award-info":[{"award-number":["P30 AI050410"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 DK007634"],"award-info":[{"award-number":["T32 DK007634"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA16086"],"award-info":[{"award-number":["P30-CA16086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002489"],"award-info":[{"award-number":["UL1TR002489"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10620-021-06829-2","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T08:03:23Z","timestamp":1612253003000},"page":"100-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["\u201cIf I Get Cured, My Whole Quality of Life Will Change\u201d: Patients\u2019 Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1414-1846","authenticated-orcid":false,"given":"Donna M.","family":"Evon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah P.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Carda-Auten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce B.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E.","family":"Golin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"6829_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1477-7525-10-92","volume":"10","author":"L Kleinman","year":"2012","unstructured":"Kleinman L, Mannix S, Yuan Y, Kummer S, L\u2019Italien G, Revicki D. Review of patient-reported outcome measures in chronic hepatitis C. Health Qual Life Outcomes. 2012;10:92","journal-title":"Health Qual Life Outcomes."},{"key":"6829_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/hep.20659","volume":"41","author":"BMR Spiegel","year":"2005","unstructured":"Spiegel BMR, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology. 2005;41:790\u2013800","journal-title":"Hepatology."},{"key":"6829_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1525-1497.2003.20826.x","volume":"18","author":"S Zickmund","year":"2003","unstructured":"Zickmund S, Ho EY, Masuda M, Ippolito L, LaBrecque DR. \u201cThey Treated Me Like a Leper\u201d: stigmatization and the quality of life of patients with Hepatitis C. J Gen Intern Med. 2003;18:835\u2013844","journal-title":"J Gen Intern Med."},{"key":"6829_CR4","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1111\/j.1365-2702.2009.02806.x","volume":"18","author":"M Sgorbini","year":"2009","unstructured":"Sgorbini M, O\u2019Brien L, Jackson D. Living with hepatitis C and treatment: the personal experiences of patients. J Clin Nurs. 2009;18:2282\u20132291","journal-title":"J Clin Nurs."},{"key":"6829_CR5","doi-asserted-by":"publisher","first-page":"e0222186","DOI":"10.1371\/journal.pone.0222186","volume":"14","author":"D Crowley","year":"2019","unstructured":"Crowley D, Cullen W, Lambert JS, Van Hout MC. Competing priorities and second chances\u2014a qualitative exploration of prisoners\u2019 journeys through the Hepatitis C continuum of care. PLoS One. 2019;14:e0222186","journal-title":"PLoS One."},{"key":"6829_CR6","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/ijerph16111958","volume":"16","author":"JJ Jost","year":"2019","unstructured":"Jost JJ, Tempalski B, Vera T, Akiyama MJ, Mangalonzo AP, Litwin AH. Gaps in HCV knowledge and risk behaviors among young suburban people who inject drugs. Int J Environ Res Public Health. 2019;16:1958","journal-title":"Int J Environ Res Public Health."},{"key":"6829_CR7","doi-asserted-by":"publisher","first-page":"e87564","DOI":"10.1371\/journal.pone.0087564","volume":"9","author":"L Yap","year":"2014","unstructured":"Yap L, Carruthers S, Thompson S et al. A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners. PLoS One. 2014;9:e87564","journal-title":"PLoS One."},{"key":"6829_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/08870446.2015.1012195","author":"VA Sublette","year":"2015","unstructured":"Sublette VA, Smith SK, George J, McCaffery K, Douglas MW. The hepatitis C treatment experience: patients\u2019 perceptions of the facilitators of and barriers to uptake, adherence and completion. Psychol Heal. 2015. https:\/\/doi.org\/10.1080\/08870446.2015.1012195.","journal-title":"Psychol Heal."},{"key":"6829_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13278","author":"RT Higashi","year":"2020","unstructured":"Higashi RT, Jain MK, Quirk L et al. Patient and provider-level barriers to hepatitis C screening and linkage to care: a mixed-methods evaluation. J Viral Hepatol. 2020. https:\/\/doi.org\/10.1111\/jvh.13278.","journal-title":"J Viral Hepatol"},{"key":"6829_CR10","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1007\/s10620-019-05590-x","volume":"64","author":"K Patel","year":"2019","unstructured":"Patel K, Zickmund SL, Jones H et al. Determinants of hepatitis C treatment adherence and treatment completion among veterans in the direct acting antiviral era. Dig Dis Sci. 2019;64:3001\u20133012. https:\/\/doi.org\/10.1007\/s10620-019-05590-x.","journal-title":"Dig Dis Sci."},{"key":"6829_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jhep.2019.04.016","volume":"71","author":"DM Evon","year":"2019","unstructured":"Evon DM, Sarkar S, Amador J et al. Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: the PROP UP study. J Hepatol. 2019;71:486\u2013497","journal-title":"J Hepatol."},{"key":"6829_CR12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s10620-017-4499-9","volume":"62","author":"D Khanna","year":"2017","unstructured":"Khanna D, Hays RD, Shreiner AB et al. Responsiveness to change and minimally important differences of the patient-reported outcomes measurement information system gastrointestinal symptoms scales. Dig Dis Sci. 2017;62:1186\u20131192. https:\/\/doi.org\/10.1007\/s10620-017-4499-9.","journal-title":"Dig Dis Sci."},{"key":"6829_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/JPR.S93391","volume":"9","author":"D Amtmann","year":"2016","unstructured":"Amtmann D, Kim J, Chung H et al. Minimally important differences for patient reported outcomes measurement information system pain interference for individuals with back pain. J Pain Res. 2016;9:251\u2013255","journal-title":"J Pain Res."},{"key":"6829_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1136\/annrheumdis-2013-204053","volume":"74","author":"RD Hays","year":"2015","unstructured":"Hays RD, Spritzer KL, Fries JF et al. Responsiveness and minimally important difference for the patient-reported outcomes measurement information system (PROMIS) 20-item physical functioning short form in a prospective observational study of rheumatoid arthritis. Ann Rheum Dis. 2015;74:104\u2013107","journal-title":"Ann Rheum Dis."},{"key":"6829_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cgh.2019.07.047","volume":"18","author":"ZM Younossi","year":"2020","unstructured":"Younossi ZM, Stepanova M, Racila A et al. Long-term benefits of sustained virologic response for patient-reported outcomes in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2020;18:468\u2013476","journal-title":"Clin Gastroenterol Hepatol."},{"key":"6829_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12879-016-1771-0","volume":"16","author":"AR Armstrong","year":"2016","unstructured":"Armstrong AR, Herrmann SE, Chassany O et al. The International development of PROQOL-HCV: an instrument to assess the health-related quality of life of patients treated for Hepatitis C virus. BMC Infect Dis. 2016;16:443","journal-title":"BMC Infect Dis."},{"key":"6829_CR17","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.17269\/CJPH.108.5782","volume":"108","author":"AC Wagner","year":"2017","unstructured":"Wagner AC, Maclean R. Preliminary investigation of the STBBI stigma scale: description and pilot results. Can J Public Heal. 2017;108:e368\u2013e373","journal-title":"Can J Public Heal."},{"key":"6829_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.drugpo.2014.10.006","volume":"26","author":"DC Perlman","year":"2015","unstructured":"Perlman DC, Jordan AE. Using qualitative data, people\u2019s perceptions, and the science of decision making to inform policy and improve hepatitis C care for people who use drugs. Int J Drug Policy. 2015;26:217\u2013219","journal-title":"Int J Drug Policy."},{"key":"6829_CR19","unstructured":"U.S. Food and Drug Administration (FDA). FDA Patient-focused drug development guidance series for enhancing the incorporation of the patient\u2019s voice in medical product development and regulatory decision making. https:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/ucm610279.htm. Published 2019. Accessed March 20, 2020."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06829-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06829-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06829-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T19:46:08Z","timestamp":1641584768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06829-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6829"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06829-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Donna M. Evon has received research funding from Gilead Sciences, Inc. and Merck Sharp and Dohme. Michael W. Fried has received research funding from and served as a consultant for AbbVie, BMS, Gilead, Merck, and TARGET PharmaSolutions. Stock in TARGET PharmaSolutions is held in an independently managed trust. Angela Edwards, Jessica Carda-Auten, Bryce B. Reeve, Carol E. Golin, and Hannah P. Kim declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}